Cart
sales@molnova.com
Saccharin
CAS No. 81-07-2
Saccharin( —— )
Catalog No. M16028 CAS No. 81-07-2
Flavoring agent and non-nutritive sweetener.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSaccharin
-
NoteResearch use only, not for human use.
-
Brief DescriptionFlavoring agent and non-nutritive sweetener.
-
DescriptionFlavoring agent and non-nutritive sweetener. (In Vitro):In vitro, saccharin (0.5, 2.5, 5 mM) inhibits bacterial growth in a species-dependent manner.(In Vivo):In vivo, saccharin (oral; 5 mg/kg; twice a day) intake reduces fecal bacterial load and alters microbiome composition, while the intestinal barrier is not obviously affected in male C57BL/6JRj wild type (wt) mice.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number81-07-2
-
Formula Weight183.18
-
Molecular FormulaC7H5NO3S
-
Purity>98% (HPLC)
-
SolubilityWater: 4,000 mg/L
-
SMILESO=C1NS(=O)(=O)C2=CC=CC=C12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Just T, et al. Appetite. 2008 Nov;51(3):622-7.
molnova catalog
related products
-
Nonaethylene glycol ...
Nonaethylene glycol monododecyl ether is a nonionic surfactant and polyethylene glycol (PEG) detergent. It can be used to form initial coalesced O/W emulsion droplets and for protein separation and purification.
-
Matairesinoside
Matairesinoside is a natural product from Styrax japonica.
-
3-Hydroxybakuchiol
3-Hydroxybakuchiol exerts cytotoxic and anti-proliferative effects on the TA3/Ha mouse mammary adenocarcinoma cell line and induces a decrease in the mitochondrial transmembrane potential, the activation of caspase-3, the opening of the mitochondrial permeability transport pore (MPTP) and nuclear DNA fragmentation.3-Hydroxybakuchiol has antitumor activity resulting from interactions with the ETC, a system that is already deficient in cancer cells.
